Diaceutics PLC
Company Profile
Business description
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives. Geographically, it operates in UK, North America, Europe, and Asia and Rest of World.
Contact
Kings Hall Health and Wellbeing Park
Dataworks, First Floor, Building Two
Antrim
BelfastBT9 6GW
GBRSector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
213
Stocks News & Analysis
stocks
AMD earnings: Data center demand still looks quite strong to us
stocks
PayPal earnings: Growth slows, new CEO appointed
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,145.70 | 35.20 | -0.38% |
| CAC 40 | 8,262.16 | 82.66 | 1.01% |
| DAX 40 | 24,603.04 | 177.75 | -0.72% |
| Dow JONES (US) | 49,501.30 | 260.31 | 0.53% |
| FTSE 100 | 10,402.34 | 87.75 | 0.85% |
| HKSE | 26,506.33 | 340.99 | -1.27% |
| NASDAQ | 22,904.58 | 350.61 | -1.51% |
| Nikkei 225 | 53,738.03 | 555.33 | -1.02% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,882.72 | 35.09 | -0.51% |
| S&P/ASX 200 | 8,880.10 | 23.90 | -0.27% |
| SSE Composite Index | 4,059.91 | 42.29 | -1.03% |